Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University Experience

被引：0

作者：

Wudhikarn, Kitsada ^{[1
]}

Lavori, Philip ^{[2
]}

Arai, Sally ^{[1
]}

Johnston, Laura ^{[1
]}

Laport, Ginna G. ^{[1
]}

Lowsky, Robert ^{[1
]}

Miklos, David B. ^{[1
]}

Shizuru, Judith A. ^{[1
]}

Hoppe, Richard T. ^{[3
]}

Benjamin, Jonathan ^{[1
]}

Meyer, Everett ^{[1
]}

Negrin, Robert ^{[1
]}

Weng, Wen-Kai ^{[1
]}

机构：

[1] Stanford Univ, Med Ctr, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA

[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[3] Stanford Univ, Med Ctr, Stanford, CA 94305 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 02期

关键词：

D O I：

10.1016/j.bbmt.2013.12.262

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

235

引用

页码：S164 / S164

页数：1

共 50 条

[21] Outcome of Hodgkin's Lymphoma Patients Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
Sarina, B.
Vai, A.
Garcia, S.
Granata, A.
Crocchiolo, R.
Bramanti, S.
Coso, D.
Bouabdallah, R.
Broussais, F.
Giordano, L.
Morabito, L.
Santoro, A.
Blaise, D.
Castagna, L.
BONE MARROW TRANSPLANTATION, 2015, 50 : S279 - S279
[22] The Role of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphoma
Holmberg, Leona
Maloney, David G.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (09): : 1060 - 1071
[23] Outcome of autologous stem-cell transplantation in Hodgkin and non hodgkin lymphoma patients
Soyer, N.
Mutlu, C. Atmaca
Vural, F.
Tombuloglu, M.
Tobu, M.
Sahin, F.
Saydam, G.
BONE MARROW TRANSPLANTATION, 2015, 50 : S289 - S290
[24] Autologous hematopoietic stem cell transplantation for high-risk Hodgkin's disease: a single-center experience with the first 100 patients
Holowiecki, J
Giebel, S
Wojnar, J
Krawczyk-Kulis, M
Stella-Holowiecka, B
Kachel, L
Wojciechowska, M
Markiewicz, M
Kata, D
TRANSPLANTATION PROCEEDINGS, 2002, 34 (08) : 3378 - 3383
[25] Non-myeloablative allogeneic stem cell transplantation in patients with high-risk lymphoma: a multicentre experience
Console, G.
Irrera, G.
Martino, M.
Messina, G.
Pucci, G.
Moscato, T.
Fedele, R.
Massara, E.
Cuzzola, M.
Pontari, A.
Callea, I.
Dattola, A.
Garreffa, C.
Spiniello, E.
Meliado, A.
Rigolino, C.
Del Vecchio, T.
Iacopino, O.
Cannata, M. C.
Scaramozzino, P.
Bova, I.
Marcuccio, D.
Stelitano, C.
Molica, S.
Cantaffa, R.
Nocilli, L.
Mele, A.
Pavone, V.
Abbadessa, A.
Iacopino, P.
BONE MARROW TRANSPLANTATION, 2009, 43 : S388 - S388
[26] Allogeneic or autologous haematopoietic stem cell transplantation for non-Hodgkin lymphoma: status at transplantation and outcome
Ferrant, A
Van den Neste, E
Michaux, L
Durbecq, J
Latinne, D
BONE MARROW TRANSPLANTATION, 2004, 33 : S36 - S36
[27] Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma
Sureda, Anna
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (05) : 943 - +
[28] Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma
Crocchiolo, R.
Castagna, L.
Fuerst, S.
EI-Cheikh, J.
Faucher, C.
Oudin, C.
Granata, A.
Bouabdallah, R.
Coso, D.
Chabannon, C.
Balzarotti, M.
Santoro, A.
Blaise, D.
BONE MARROW TRANSPLANTATION, 2013, 48 (02) : 249 - 252
[29] Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin’s lymphoma
R Crocchiolo
L Castagna
S Fürst
J El-Cheikh
C Faucher
C Oudin
A Granata
R Bouabdallah
D Coso
C Chabannon
M Balzarotti
A Santoro
D Blaise
Bone Marrow Transplantation, 2013, 48 : 249 - 252
[30] High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience
Sperotto, A
Zaja, F
Damiani, D
Patriarca, F
Geromin, A
Fanin, R
HAEMATOLOGICA, 2001, 86 (12) : 1317 - 1318

← 1 2 3 4 5 →